open access
Chronic cough — treament in line with guidelines
, 1, 2
Affiliations- Department of Pulmonology and Allergology, Medical University of Gdansk
- Katedra i Klinika Hematologii i Transplantologii, Gdański Uniwersytet Medyczny
open access
Abstract
Chronic cough is one of the most common symptoms in clinical practice that is associated numerous
negative consequences. The pathophysiology of chronic cough is complex, and its most common causes
include respiratory diseases, neurological disorders, exposure to tobacco smoke, and medications.
Understanding the physiology of cough and the mechanisms of cough hypersensitivity can improve
the outcome of the treatment. At the turn of 2019 and 2020, the European Respiratory Society (ERS)
issued guidelines concerning diagnostic evaluation and therapeutic management (pharmacological
and non-pharmacological treatment) of chronic cough that persists despite causal treatment as well as
cough of unknown etiology.
The aim of the treatment, preceded by a thorough clinical evaluation, is to control the cough reflex
while maintaing the protective function of cough. The following aspects should be taken into account
in therapeutic management: antiasthmatic medications, medications reducing gastric acidity as well as
prokinetic and neuromodulatory medications. Non-pharmacological methods include physiotherapy and
speech therapy. To improve treatment results, it is necessary to seek new antitussive medications and
physiotherapy methods, understand cough phenotypes and introduce more effective methods of cough
measurement. Due to the limited efficacy of the currently used medications, researchers are currently
conducting clinical trials involving new antitussive medications, with mechanisms of antitussive activity
other than the ones which are currently applied.
Abstract
Chronic cough is one of the most common symptoms in clinical practice that is associated numerous
negative consequences. The pathophysiology of chronic cough is complex, and its most common causes
include respiratory diseases, neurological disorders, exposure to tobacco smoke, and medications.
Understanding the physiology of cough and the mechanisms of cough hypersensitivity can improve
the outcome of the treatment. At the turn of 2019 and 2020, the European Respiratory Society (ERS)
issued guidelines concerning diagnostic evaluation and therapeutic management (pharmacological
and non-pharmacological treatment) of chronic cough that persists despite causal treatment as well as
cough of unknown etiology.
The aim of the treatment, preceded by a thorough clinical evaluation, is to control the cough reflex
while maintaing the protective function of cough. The following aspects should be taken into account
in therapeutic management: antiasthmatic medications, medications reducing gastric acidity as well as
prokinetic and neuromodulatory medications. Non-pharmacological methods include physiotherapy and
speech therapy. To improve treatment results, it is necessary to seek new antitussive medications and
physiotherapy methods, understand cough phenotypes and introduce more effective methods of cough
measurement. Due to the limited efficacy of the currently used medications, researchers are currently
conducting clinical trials involving new antitussive medications, with mechanisms of antitussive activity
other than the ones which are currently applied.
Keywords
chronic cough, physiology of cough, cough treatment, cough hypersensitivity
About this articleTitle
Chronic cough — treament in line with guidelines
Journal
Palliative Medicine in Practice
Issue
Article type
Review paper
Pages
69-76
Published online
2021-10-28
Page views
4847
Article views/downloads
326
DOI
Bibliographic record
Palliat Med Pract 2022;16(1):69-76.
Keywords
chronic cough
physiology of cough
cough treatment
cough hypersensitivity
Authors
Iwona Damps-Konstańska
Tomasz Nadolny
Ewa Jassem
References (29)- Morice AH, Fontana GA, Belvisi MG, et al. European Respiratory Society (ERS). ERS guidelines on the assessment of cough. Eur Respir J. 2007; 29(6): 1256–1276.
- Song WJ, Chang YS, Faruqi S, et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J. 2015; 45(5): 1479–1481.
- Morice AH, Jakes AD, Faruqi S, et al. Chronic Cough Registry. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J. 2014; 44(5): 1149–1155.
- Chamberlain SAF, Garrod R, Douiri A, et al. The impact of chronic cough: a cross-sectional European survey. Lung. 2015; 193(3): 401–408.
- Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020; 55(1).
- Dicpinigaitis PV, Kantar A, Enilari O, et al. Prevalence of Arnold Nerve Reflex in Adults and Children With Chronic Cough. Chest. 2018; 153(3): 675–679.
- Mazzone S, McGarvey L. Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough. Clinical Pharmacology & Therapeutics. 2020; 109(3): 619–636.
- Driessen A. Vagal Afferent Processing by the Paratrigeminal Nucleus. Frontiers in Physiology. 2019; 10.
- Gold MS, Flake NM. Inflammation-mediated hyperexcitability of sensory neurons. Neurosignals. 2005; 14(4): 147–157.
- Muccino D, Morice A, Birring S, et al. Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough. ERJ Open Research. 2020; 6(4): 00284–2020.
- Arinze J, Roos Ede, Karimi L, et al. Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study. ERJ Open Research. 2020; 6(2): 00300–2019.
- Boulet LP, Coeytaux R, McCrory D, et al. Tools for Assessing Outcomes in Studies of Chronic Cough. Chest. 2015; 147(3): 804–814.
- Dąbrowska M, Krakowiak K, Radlińska O, et al. Validation of the Polish Version of the Chronic Cough Quality of Life Questionnaire (Leicester Cough Questionnaire). Adv Clin Exp Med. 2016; 25(4): 649–653.
- Lee SE, Lee JiH, Kim HJ, et al. Inhaled Corticosteroids and Placebo Treatment Effects in Adult Patients With Cough: A Systematic Review and Meta-analysis. Allergy Asthma Immunol Res. 2019; 11(6): 856–870.
- Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. The Lancet. 2003; 361(9356): 449–456.
- Côté A, Russell RJ, Boulet LP, et al. CHEST Expert Cough Panel. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report. Chest. 2020; 158(1): 68–96.
- Brożek B, Damps-Konstańska I, Pierzchała W, et al. End-of-life care for patients with advanced lung cancer and chronic obstructive pulmonary disease: survey among Polish pulmonologists. Pol Arch Intern Med. 2019; 129(4): 242–252.
- Slinger C, Mehdi SB, Milan SJ, et al. Speech and language therapy for management of chronic cough . Cochrane Database of Systematic Reviews. 2019; 7(CD013067).
- Ribeiro VV, Lopes LW, Behlau M. Presentation of the Therapy Program for Management of Chronic Cough. Codas. 2021; 33(3): e20200057.
- Truba O, Rybka A, Klimowicz K, et al. Is a normal chest radiograph sufficient to exclude pulmonary abnormalities potentially associated with chronic cough? Adv Respir Med. 2018; 86(3): 268–274.
- A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough, 2018. ClinicalTrials.gov ( 22 September 2021).
- Abdulqawi R, Satia I, Kanemitsu Y, et al. A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough. The Journal of Allergy and Clinical Immunology: In Practice. 2021; 9(4): 1640–1647.
- Żylicz Z. Co wiemy na temat leczenia kaszlu w opiece paliatywnej? Medycyna Paliatywna w Praktyce. 2014; 8(3): 120–124.
- https://www.uptodate.com/contents/palliative-care-overview-of-cough-stridor-and-hemoptysis-in-adults (22 September 2021).
- Lin YL, Lin IC, Liou JC. Symptom patterns of patients with head and neck cancer in a palliative care unit. J Palliat Med. 2011; 14(5): 556–559.
- De Walden-Gałuszko K, Ciałkowska-Rysz A. Medycyna Paliatywna. PZWL, Warszawa 2015: 131–134.
- Zylicz Z, Krajnik M. What has dry cough in common with pruritus? Treatment of dry cough with paroxetine. J Pain Symptom Manage. 2004; 27(2): 180–184.
- Ventresca PG, Nichol GM, Barnes PJ, et al. Inhaled furosemide inhibits cough induced by low chloride content solutions but not by capsaicin. Am Rev Respir Dis. 1990; 142(1): 143–146.
- Truesdale K, Jurdi A. Nebulized lidocaine in the treatment of intractable cough. Am J Hosp Palliat Care. 2013; 30(6): 587–589.
